Publications in collaboration with researchers from Universidad del País Vasco/Euskal Herriko Unibertsitatea (9)

2021

  1. A retrospective study on the potential of 99mTc-HDP imaging before therapy for individualizing treatments with 223Ra-Cl2 for metastatic castration resistant prostate cancer

    Medical Physics, Vol. 48, Núm. 3, pp. 1395-1403

  2. Dependency of the remnant 131I-NaI biokinetics on the administered activity in patients with differentiated thyroid cancer

    Physica Medica, Vol. 88, pp. 45-52

2020

  1. Feasibility and limitations of quantitative SPECT for 223Ra

    Physics in Medicine and Biology, Vol. 65, Núm. 8

  2. Oligometastatic prostate adenocarcinoma. Clinical-pathologic study of a histologically under-recognized prostate cancer

    Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-9

2019

  1. Analysis of activity uptake, effective half-life and time-integrated activity for low- and high-risk papillary thyroid cancer patients treated with 1.11 GBq and 3.7 GBq of 131I-NaI respectively

    Physica Medica, Vol. 65, pp. 143-149

2018

  1. Comparison of microdosimetry-based absorbed doses to control tumours and clinically obtained tumour absorbed doses in treatments with 223Ra

    Physics in Medicine and Biology, Vol. 63, Núm. 14

2017

  1. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma

    Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1337-1349

2007

  1. Diagnostic efficacy of sentinel node biopsy in oral squamous cell carcinoma. Cohort study and meta-analysis

    Medicina Oral, Patologia Oral y Cirugia Bucal, Vol. 12, Núm. 3, pp. 201-209

  2. Diagnostic efficacy of sentinel node biopsy in oral squamous cell carcinoma: cohort study and meta-analysis

    Medicina oral, patología oral y cirugía bucal. Ed. inglesa, Vol. 12, Núm. 3, pp. 14